USFDA Grants Orphan Drug Status to Zydus’ Desidustat for Sickle Cell Disease
New Delhi: Zydus Lifesciences Limited on Wednesday announced that the United States Food and Drug Administration (USFDA) has granted Orphan Drug Designation (ODD) to its novel New Chemical Entity (NCE)…